Amarin Decision Update: To Europe and Beyond
As the world waits for COVID-19 vaccines to become widely available, Amarin experiences a different form of anticipation, one which will see the fate of
As the world waits for COVID-19 vaccines to become widely available, Amarin experiences a different form of anticipation, one which will see the fate of
Image from the StarTribune. https://www.startribune.com/u-of-m-nurse-practitioner-clinic-aims-to-help-fill-doctor-void/297468881/ After heading into a clinic and filling out the required forms, the assistant calls you back. “Wait in room number
Image from Newsday. https://www.newsday.com/opinion/editorial/cure-vaccine-immunity-coronavirus-covid-19-rush-trump-science-1.48679327 With everyone is rushing to return pre-pandemic society, it is becoming clear that a vaccine is the only way to truly
Mergers and acquisitions are a hot topic in the biopharmaceutical industry. With 2019 setting records in terms of deal value and volume for biopharmaceutical M&A,
In a relatively quick ruling, one that Amarin expected to occur in Q4 at the earliest, the U.S Court of Appeals for the Federal Circuit
Time is ticking! Need to optimize the value of a new therapy before generics are available. How can we extend the patent? These are all
In a recent interview with Fox News host Chris Wallace, US President Donald Trump discussed his success taking the Montreal Cognitive Assessment (MoCA). The President
We all know one size never fits all, yet, for the vast majority of medical history, care providers have been using that approach. Fortunately, with
Many debates have been held on the merits of social media. When it comes to the health care industry, the terms “key opinion leaders (KOLs)”
Often the sites of harrowing injuries, trauma centers are a vital part of the U.S healthcare system. Trauma centers save lives. According to the New